Leserbrief
Key questions remain about GLP-1 drug discontinuation
BMJ · 30.03.2026 · 392 · s575
DOI: 10.1136/bmj.s575 ↗Kurz gefasst
Leserbrief in der Zeitschrift BMJ, online erschienen am 30.03.2026. Verfasst von Dhanesh D Binda und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Montefiore Medical Center, Albert Einstein College of Medicine, NY, USA. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Anesthesiology, Montefiore Medical Center, Albert Einstein College of Medicine, NY, USA.
- Boston Medical Center-Brighton, Boston, MA, USA.
- Department of Anesthesiology, Boston Medical Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
Zitieren
APA
Binda, D. D., & Nozari, A. (2026). Key questions remain about GLP-1 drug discontinuation. BMJ, 392, s575. https://doi.org/10.1136/bmj.s575
Vancouver
Binda DD, Nozari A. Key questions remain about GLP-1 drug discontinuation. BMJ. 2026;392:s575. doi:10.1136/bmj.s575
BibTeX
@article{Binda2026,
author = {Binda, Dhanesh D and Nozari, Ala},
title = {Key questions remain about GLP-1 drug discontinuation},
journal = {BMJ},
year = {2026},
volume = {392},
pages = {s575},
doi = {10.1136/bmj.s575}
}
EUVIMED